The chief of the lymphoma division and oncologist at Levine Cancer Institute discussed work that needs to be done to support the use of CAR T therapy.
Susan Ruediger, founder and chief mission officer, CMT Research Foundation, discussed the origins of the CMTRF.
The professor of neurosurgery at Rush University Medical School discussed the potential of Lineage Cell’s LCTOPC1 cell therapy.